Boston Scientific recalls RotaWire Elite core wires

Boston Scientific recalled its RotaWire Elite Guidewires and wireClip Torquer Guidewires after receiving three reports of the wires cracking and separating from the Rotablator Rotational Atherectomy System.

Boston Scientific sent a recall letter beginning on Oct. 9 to customers telling them to immediately stop distributing and using the devices and return the affected products to Boston Scientific.

The FDA announced the recall on Nov. 27 and classified it as a Class I recall, which is the most serious type of recall.

In its recall letter, Boston Scientific mentioned the wires might crack and separate from the rest of the system and cause serious injury such as MI, tamponade and migration of wire fragments elsewhere in the body.

Of the three reports, one resulted in a patient dying after undergoing a medical intervention to remove the broken wire. When the issue has occurred, interventions have included occluding the affected artery, placing stents in the affected artery and performing emergency heart surgery.

The recall included 600 devices in 17 states that were manufactured from June 26, 2015 to Sept. 10, 2015 and distributed from July 9, 2015 to Oct. 1, 2015.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.